Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where V. A. Forsaa is active.

Publication


Featured researches published by V. A. Forsaa.


Acta Ophthalmologica | 2013

Short‐term postoperative non‐supine positioning versus strict face‐down positioning in macular hole surgery

V. A. Forsaa; Sten Raeder; L. T. Hashemi; Jørgen Krohn

Purpose:  The purpose of this study was to compare the efficacy of short‐term non‐supine positioning (NSP) and strict face‐down positioning (FDP) in the repair of macular hole (MH).


Retina-the Journal of Retinal and Vitreous Diseases | 2017

AIR TAMPONADE COMBINED WITH NONSUPINE POSITIONING IN MACULAR HOLE SURGERY FOR PSEUDOPHAKIC EYES.

V. A. Forsaa; Jørgen Krohn

Purpose: To investigate the closure rate of primary full-thickness macular hole, following intraocular air tamponade combined with a nonsupine positioning regimen. Methods: A prospective study of patients with full-thickness macular hole, who underwent pars plana vitrectomy with internal limiting membrane peeling and intraocular air tamponade followed by 3 days of nonsupine positioning. Outcome measures were primary full-thickness macular hole closure and improvement in best-corrected visual acuity after 6 months. Results: A total of 34 eyes were included. In the group of full-thickness macular hole ⩽400 &mgr;m, primary closure occurred in 95% (19/20), whereas only 57% (8/14) of those >400 &mgr;m closed (P = 0.01). The mean gain in best-corrected visual acuity was 3.5 ETDRS (Early Treatment Diabetic Retinopathy Study) lines (SD = 1.5) (P < 0.01). The air bubble meniscus height at the first postoperative day was estimated to a mean of 59% (range, 50–70%), at the second postoperative day it was 46% (range, 40–55%), and the third day it was 39% (range, 30–45%). Mean intraocular air bubble duration was 10 days (range, 8–13 days). Conclusion: The combination of air tamponade and nonsupine positioning regimen leads to high closure rates for small/medium macular holes (⩽400 &mgr;m), but not for large macular holes (>400 &mgr;m).


Ophthalmology | 2016

Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol:Two-Year Results

Karina Berg; Emina Hadzalic; Inger Gjertsen; V. A. Forsaa; Lars Haakon Berger; Bettina Kinge; Hans Jørgen Henschien; Kristian Fossen; Slavica Markovic; Terje R. Pedersen; Leiv Sandvik; Ragnheiður Bragadóttir


Retina-the Journal of Retinal and Vitreous Diseases | 2016

POSTOPERATIVE POSITIONING IN MACULAR HOLE SURGERY: An Objective Evaluation of Nonsupine Positioning and the Effect of the "Tennis Ball Technique".

V. A. Forsaa; Jørgen Krohn


Acta Ophthalmologica | 2018

Epidemiology and morphology of full-thickness macular holes

V. A. Forsaa; Birger Lindtjørn; Jan Terje Kvaløy; Torbjørn Frøystein; Jørgen Krohn


Investigative Ophthalmology & Visual Science | 2011

Strict Face Down Positioning Compared With No Face Down Positioning In The Repair Of Macular Hole

V. A. Forsaa; L. T. Hashemi; Sten Raeder; Joergen Krohn


Investigative Ophthalmology & Visual Science | 2011

The MicroRNA And MessengerRNA Gene Expression Signature Of Human Primary Pterygium

David H. Engelsvold; Harald F. Ulltveit-Moe; Ole Kristoffer Olstad; Tor Paaske Utheim; Jon Roger Eidet; Øygunn Aass Utheim; V. A. Forsaa; Marketa Jenssen; Torstein Lyberg; Sten Raeder


Investigative Ophthalmology & Visual Science | 2011

Vitrectomy and Submacular Tissue Plasminogen Activator in the Management of Acute Submacular Hemorrhage

L. T. Hashemi; V. A. Forsaa


/data/revues/00029394/v150i3/S0002939410002539/ | 2011

Efficacy of Ranibizumab in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion: Results From the Sham-Controlled ROCC Study

Bettina Kinge; Per Bjørn Stordahl; V. A. Forsaa; Kristian Fossen; Marta Haugstad; Ole Harald Helgesen; Johan H. Seland; Ingar Stene-Johansen


Investigative Ophthalmology & Visual Science | 2010

When Your Anti-VEGF Agent Fails, Will the Other One Succeed?

L. T. Hashemi; Sten Raeder; A. Takserman; Harald F. Ulltveit-Moe; V. A. Forsaa

Collaboration


Dive into the V. A. Forsaa's collaboration.

Top Co-Authors

Avatar

L. T. Hashemi

Stavanger University Hospital

View shared research outputs
Top Co-Authors

Avatar

Sten Raeder

Stavanger University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Takserman

Stavanger University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David H. Engelsvold

Stavanger University Hospital

View shared research outputs
Top Co-Authors

Avatar

P. Bjerga

Stavanger University Hospital

View shared research outputs
Top Co-Authors

Avatar

Birger Lindtjørn

Stavanger University Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge